DE2822751C2 - - Google Patents

Info

Publication number
DE2822751C2
DE2822751C2 DE2822751A DE2822751A DE2822751C2 DE 2822751 C2 DE2822751 C2 DE 2822751C2 DE 2822751 A DE2822751 A DE 2822751A DE 2822751 A DE2822751 A DE 2822751A DE 2822751 C2 DE2822751 C2 DE 2822751C2
Authority
DE
Germany
Prior art keywords
compound
formula
group
oxo
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2822751A
Other languages
German (de)
English (en)
Other versions
DE2822751A1 (de
Inventor
Michael Peter Lear Caton
Edward Charles John Upminster Essex Gb Coffee
Gordon Leonard Burbank Calif. Us Watkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of DE2822751A1 publication Critical patent/DE2822751A1/de
Application granted granted Critical
Publication of DE2822751C2 publication Critical patent/DE2822751C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19782822751 1977-05-26 1978-05-24 Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen Granted DE2822751A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB22319/77A GB1581886A (en) 1977-05-26 1977-05-26 Prostanol derivatives

Publications (2)

Publication Number Publication Date
DE2822751A1 DE2822751A1 (de) 1978-12-07
DE2822751C2 true DE2822751C2 (enExample) 1988-01-28

Family

ID=10177472

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782822751 Granted DE2822751A1 (de) 1977-05-26 1978-05-24 Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen

Country Status (9)

Country Link
US (1) US4158062A (enExample)
JP (1) JPS53147045A (enExample)
DE (1) DE2822751A1 (enExample)
FR (1) FR2392005A1 (enExample)
GB (1) GB1581886A (enExample)
HK (1) HK28784A (enExample)
IT (1) IT1094851B (enExample)
MY (1) MY8400370A (enExample)
SG (1) SG59183G (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512344D0 (en) * 1985-05-15 1985-06-19 May & Baker Ltd Compositions of matter
JPH085794B2 (ja) * 1989-07-27 1996-01-24 株式会社上野製薬応用研究所 高脂質血症処置・血中脂質成分低下剤
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
JP4889219B2 (ja) * 2002-12-27 2012-03-07 スキャンポ・アーゲー 腹部不快感の処置のためのプロスタグランジン誘導体
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
US20090030072A1 (en) 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives

Also Published As

Publication number Publication date
HK28784A (en) 1984-04-06
JPS53147045A (en) 1978-12-21
IT1094851B (it) 1985-08-10
MY8400370A (en) 1984-12-31
IT7823915A0 (it) 1978-05-26
GB1581886A (en) 1980-12-31
FR2392005B1 (enExample) 1980-04-04
SG59183G (en) 1984-07-27
DE2822751A1 (de) 1978-12-07
JPS6151584B2 (enExample) 1986-11-10
FR2392005A1 (fr) 1978-12-22
US4158062A (en) 1979-06-12

Similar Documents

Publication Publication Date Title
DE2437135C2 (de) Δ↑6↑↑a↑(↑1↑↑0↑↑a↑)-1-Amino-3-substituierte-7,8,9,10-tetrahydro-6,6.9-trimethyl-6H-dibenzo[b,d]pyrane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2305092C2 (enExample)
DE2229035A1 (de) Cyclopentanderivate
DE69104948T2 (de) Spiro[4,5]decanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE2822751A1 (de) Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
AT391320B (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DE2632118B2 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2350148A1 (de) Thiophenderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE1470074C3 (de) 1,2,3,4,6,7-Hexahydro-l lbH-benzo eckige Klammer auf a eckige Klammer zu chinolizine sowie deren Acetate und/oder phsiologisch verträgliche Säureadditionssalze sowie Verfahren zu ihrer Herstellung
CH634839A5 (de) Pyranochromonderivate und ihre verwendung in arzneimitteln zur behandlung von allergien.
DE2502919C2 (de) Cyclopentan-Derivate, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
DE3121175A1 (de) Erythro-1,2,3-triphenyl-1-pentanon-derivate sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0496274A1 (de) Tricyclisches Pyridonderivat
DE2949003C2 (enExample)
DE2753791A1 (de) Derivate von vincaalkaloiden, verfahren zu ihrer herstellung und arzneimittel
DE2530515C2 (de) 4- bzw. 7-Hydroxy-4,5,6,7-tetrahydrothieno-[3,2-c] bzw.[2,3-c] pyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittelzubereitungen
DE69018741T2 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.
EP0088986A2 (de) Bicyclische Phenolether, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2842418A1 (de) Indol-verbindungen
DE2640692C3 (de) Optisch aktive 5- (2-Carboxythiophen5-yl)-16phenoxy- a -tetranor- w tetranor-prostaglandine
DE2529792A1 (de) Antidepressive verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2627190A1 (de) Neue fuenfring-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
AT357555B (de) Verfahren zum herstellen von neuen spiro-(1,3- dioxolan-4,3')chinuclidinen, ihren salzen und isomeren
DE69612626T2 (de) Hydrat-kristall und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8380 Miscellaneous part iii

Free format text: SPALTE 1, ZEILE 4 "...13, 14-DIHYDRO-2-DES CARBOXY-..." AENDERN IN "...13, 14-DIHYDRO-2-DECARBOXY...."

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee